Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. KRISTALOSE AGREEMENT Between CUMBERLAND PHARMACEUTICALS INC. And INALCO BIOCHEMICALS, INC. And INALCO...Kristalose Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Abbreviations LTL lactulose; LTS lactose; EPI epilactose; GLT galactose; ND carbohydrates different from LTL, LTS, EPI, and GLT.
Certain portions of this document have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. THIRD AMENDMENT TO KRISTALOSE AGREEMENTKristalose Agreement • May 12th, 2009 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Third Amendment to Kristalose Agreement (the “Third Amendment”) is entered into this 6th day of April, 2009 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDMENT TO KRISTALOSE AGREEMENTKristalose Agreement • August 12th, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Second Amendment to Kristalose Agreement (the “Amendment”) is entered into this 1st day of July, 2008 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. AMENDMENT TO KRISTALOSE AGREEMENTKristalose Agreement • May 21st, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment to Kristalose Agreement (the “Amendment”) is entered into this 3rd day of April, 2008 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FOURTH AMENDMENT TO KRISTALOSE AGREEMENTKristalose Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
This Fourth Amendment to Kristalose Agreement (the “Fourth Amendment”) is effective this 1st day of January, 2010 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”
